Commonly used drugs for immunotherapy of renal cancer

What are the commonly used drugs for immunotherapy of kidney cancer? Kidney cancer accounts for 3% of all malignant tumors, and the incidence rate is also increasing year by year. Immunotherapy is a common method for treating kidney cancer. Currently, commonly used drugs mainly include BCG, interferon, immune RNA, interleukin-2, etc.

1. BCG: BCG therapy is a non-specific immunotherapy method that can amplify the effects of cellular and antibody immune responses through immune-active cells to enhance the body's immunity and anti-tumor ability. It can be used alone or in combination with other drugs.

2. Interferon: The main function of interferon is to regulate and induce the body's immune function, activate T lymphocytes to produce and release lymphokines, and then activate macrophages to enhance the tumor-killing effect.

3. Immune RNA: Immune RNA can shrink advanced renal cancer, and clinical side effects and adverse reactions are relatively rare. It is currently commonly used to treat renal cancer.

4. Interleukin-2: The function of interleukin-2 is to induce the anti-tumor activity of LAK cells, dissolve a variety of tumor cells, and cause degeneration and necrosis of tumor cells. When used in combination with LAK cells, it can enhance the immune activity of LAK cells and T cells and enhance the effect of killing tumors.

Tips: Interferon often causes flu-like symptoms when used, such as fever, chills, muscle pain, loss of appetite, vomiting, etc. The patient's condition should be fully considered when using it.